William Valle

CIK: 0002018493

Transaction Breakdown

Open Market Buys (P)1 (16.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TLSI

TriSalus Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

TLSI
TriSalus Life Sciences, Inc.
May 14, 2026
Award(A)
Direct
28.2K shares-
TLSI
TriSalus Life Sciences, Inc.
May 14, 2026
Award(A)
Direct
24.6K shares-
TLSI
TriSalus Life Sciences, Inc.
Feb 23, 2026
Purchase(P)
Direct
30.5K shares at avg. $4.10$125K
TLSI
TriSalus Life Sciences, Inc.
Jun 12, 2025
Award(A)
Director Stock Option (right to buy)
Direct
15K shares-
TLSI
TriSalus Life Sciences, Inc.
Jan 29, 2025
Award(A)
Director Stock Option (right to buy)
Direct
35K shares-
TLSI
TriSalus Life Sciences, Inc.
Jan 29, 2025
Award(A)
Director Stock Option (right to buy)
Direct
6.3K shares-

		Type	Shares	Price		Ownership
May 14, 2026	TLSI TriSalus Life Sciences, Inc.	Award(A)	28,201	-	$0	Direct
May 14, 2026	TLSI TriSalus Life Sciences, Inc.	Award(A)	24,553	-	$0	Direct
Feb 23, 2026	TLSI TriSalus Life Sciences, Inc.	Purchase(P)	30,487	$4.10	$124,997	Direct
Jun 12, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A) Director Stock Option (right to buy)	15,000	-	-	Direct
Jan 29, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A) Director Stock Option (right to buy)	35,000	-	-	Direct
Jan 29, 2025	TLSI TriSalus Life Sciences, Inc.	Award(A) Director Stock Option (right to buy)	6,250	-	-	Direct

1-6 of 6 transactions

About Valle William

Valle William (SEC CIK 0002018493) files insider reports with the SEC as Director of TriSalus Life Sciences, Inc. (TLSI).

Signal8 holds 5 ownership filings by Valle William (1 Form 3, 4 Form 4), filed between Jan 31, 2025 and May 15, 2026. Those filings report 6 transactions, from Jan 29, 2025 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Valle William's filings is in WESTMINSTER, CO.

Recent filings by Valle William

May 14, 2026: Grants or awards of TLSI shares (2 lines, Form 4, code A).
Feb 23, 2026: Open-market purchase of TLSI shares (Form 4, code P).
Jun 12, 2025: Grant or award of TLSI derivative securities (Form 4, code A).
Jan 29, 2025: Grants or awards of TLSI derivative securities (2 lines, Form 4, code A).

Other insiders filing for TriSalus Life Sciences, Inc. (TLSI)

Cox Bryan F., Chief of Research
Marshak Richard, Chief Commercial Officer
Stevens Jennifer, Chief Regulatory Officer
Szela Mary T, CEO and President
Patience David, Chief Financial Officer
Marshall Richard Henry, Chief Medical Officer

How to read Form 4 transaction codes